UPPSALA, Sweden and BOSTON, Feb. 28, 2025 /PRNewswire/ -- MAGic BioProcessing is thrilled to welcome Ben Krol as the new Director of Sales & Business Development -North America East.

Ben joins MAGic BioProcessing from Ecolab and brings extensive expertise in chromatography resins and a deep understanding of the evolving needs of biotech and pharmaceutical industry. His insights into downstream processing and his ability to align technology with industry demands make him a valuable addition to the MAGic BioProcessing team.

For more information, please contact:
Peter Karlberg, CEO
peter@magicbioprocessing.com

or visit our webpage https://magicbioprocessing.com

About MAGic™ BioProcessing

MAGic BioProcessing (Lab-on-a-Bead AB) is a biotech tools company from Uppsala, Sweden that develops and sells proprietary magnetic-based products and methods for bioprocessing of biologics such as recombinant proteins, monoclonal antibodies, viral vectors, and cells. With a commitment to innovation and excellence, MAGic BioProcessing empowers researchers and industry professionals with cutting-edge solutions.

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/magic-bioprocessing/r/magic--bioprocessing-welcomes-a-new-team-member,c4112512

View original content:https://www.prnewswire.co.uk/news-releases/magic-bioprocessing-welcomes-a-new-team-member-302388348.html

Tags

More Like This

MAGic™ BioProcessing appoints Jonathan Royce to Board of Directors

MAGic™ BioProcessing Announces Changes to Board of Directors

MAGic™ BioProcessing Secures Patent in USA and China

Boston BioProducts Bolsters Commercial Leadership Team with New Head of Product Management

Boston BioProducts Strengthens Leadership Team, Setting New Standards in Reagent Manufacturing and Quality

BioProcess360 Partners Launches New Chromatography Company Through Transfer of IP, Assets and Personnel from LigaTrap Technologies

Ecolab Life Sciences Opens New State-of-the-Art Bioprocessing Applications Laboratory in Pennsylvania, US

BioProcess360 Partners launch dedicated Life Sciences investment fund to grow emerging bioprocessing tools and technologies